Exhibit
7
THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR
ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, EXCHANGED, HYPOTHECATED OR
TRANSFERRED IN ANY MANNER EXCEPT PURSUANT TO A REGISTRATION OR AN EXEMPTION
FROM
SUCH REGISTRATION.
PURCHASE
WARRANT
Issued
to:
Schering
AG
Exercisable
to Purchase
975,000
Shares of Common Stock
of
SONUS
PHARMACEUTICALS, INC.
Void
after October 17, 2010
This
is
to certify that, for the value described herein and subject to the terms and
conditions set forth below, the Warrantholder is entitled to purchase, and
the
Company promises and agrees to sell and issue to the Warrantholder, at any
time
on or after October 17, 2005 (the “Effective
Date”),
pursuant to Section 3 hereof, up to 975,000 shares of the Company’s Common Stock
at the Exercise Price.
This
Warrant certificate is issued subject to the following terms and
conditions:
1. Definitions
of Certain Terms.
Except
as may be otherwise clearly required by the context, the following terms have
the following meanings:
(a) “Common
Stock”
means
the common stock, $0.001 par value, of the Company.
(b) “Company”
means
Sonus Pharmaceuticals, Inc., a Delaware corporation.
(c) “Effective
Date”
has
the
meaning set forth in the preamble to this Agreement.
(d) “Exercise
Period”
means
the period of time commencing on the Effective Date and ending at 5 p.m. Pacific
Standard Time on the fifth anniversary of the Effective Date.
(e) “Exercise
Price”
means
the price at which the Warrantholder may purchase one Share upon exercise of
Warrants as determined from time to time pursuant to the provisions hereof.
The
initial Exercise Price is $4.42 per Share, which is equal to 110% of the
purchase price per share of Common Stock paid by Warrantholder under the
Securities Purchase Agreement.
(f) “Registration
Rights Agreement”
means
the Registration Rights Agreement dated as of October 17, 2005 between the
Company and the Investor referenced therein.
(g) “Securities
Act”
means
the Securities Act of 1933, as amended.
(h) “Securities
Purchase Agreement”
means
the Securities Purchase Agreement dated as of October 17, 2005 between the
Company and the Investor referenced therein.
(i) “Share”
or
“Shares”
refers
to one or more shares of Common Stock issuable on exercise of the
Warrant.
(j) “Warrant”
means
the warrant evidenced by this certificate or any certificate obtained upon
transfer or partial exercise of the Warrant evidenced by any such
certificate.
(k) “Warrantholder”
means
a
record holder of the Warrant or Shares. The initial Warrantholder is Schering
AG.
2. Purchase
of Warrant.
Concurrently with the issuance hereof, the Warrantholder shall pay to the
Company as consideration for the Warrant the sum of $0.125 per Share issuable
upon exercise of the Warrant, or $121,875 in the aggregate.
3. Exercise
of Warrants.
(a) All
or
any part of the Warrant may be exercised during the Exercise Period by
surrendering the Warrant, together with appropriate instructions, duly executed
by the Warrantholder or by its duly authorized attorney, and delivery of payment
in full by the Warrantholder, in lawful money of the United States, of the
Exercise Price payable with respect to the Shares being purchased at the office
of the Company, 22026 20th
Avenue
S.E., Bothell, Washington, 98021, Attention: President, or at such other office
or agency as the Company may designate. The date on which such instructions
and
the Exercise Price are received by the Company shall be the date of exercise.
Upon receipt of notice of exercise and the Exercise Price, the Company shall
immediately instruct its transfer agent to prepare certificates for the Shares
to be received by the Warrantholder and shall use commercially reasonable
efforts to cause such certificates to be prepared and delivered to the
Warrantholder in accordance with the Warrantholder’s instructions within three
business days after the date of exercise. If the Warrantholder shall provide
the
Company with an opinion of counsel to the effect that the legend set forth
on
the face of this Warrant is not required, such certificates shall not bear
a
legend with respect to the Securities Act.
(b) If
fewer
than all the Shares purchasable under the Warrant are purchased, the Company
will, upon such partial exercise, execute and deliver to the Warrantholder
a new
Warrant certificate (dated the date hereof), in form and tenor similar to this
Warrant certificate, evidencing that portion of the Warrant not exercised.
The
Shares to be obtained on exercise of the Warrant will be deemed to have been
issued, and any person exercising the Warrant will be deemed to have become
a
holder of record of those Shares, as of the date of the payment of the Exercise
Price.
4. Adjustments
in Certain Events.
The
number, class, and price of the Shares for which this Warrant is exercisable
are
subject to adjustment from time to time upon the happening of certain events
as
follows:
(a) If
the
outstanding shares of the Company’s Common Stock are divided into a greater
number of shares or a dividend in stock is paid on the Common Stock, the number
of Shares for which the Warrant is then exercisable will be proportionately
increased and the Exercise Price will be proportionately reduced; and,
conversely, if the outstanding shares of Common Stock are combined into a
smaller number of shares of Common Stock, the number of Shares for which the
Warrant is then exercisable will be proportionately reduced and the Exercise
Price will be proportionately increased. The increases and reductions provided
for in this subsection 4(a) will be made with the intent and, as nearly as
practicable, the effect that neither the percentage of the total equity of
the
Company obtainable on exercise of the Warrants nor the price payable for such
percentage upon such exercise will be affected by any event described in this
subsection 4(a).
(b) In
case
of any change in the Common Stock through merger, consolidation,
reclassification, reorganization, partial or complete liquidation, purchase
of
substantially all the assets of the Company, or other change in the capital
structure of the Company, then, as a condition of such change, lawful and
adequate provision will be made so that the holder of this Warrant will have
the
right thereafter to receive upon the exercise of the Warrant the kind and amount
of shares of stock or other securities or property to which he would have been
entitled if, immediately prior to such event, he had held the number of Shares
obtainable upon the exercise of the Warrant. In any such case, appropriate
adjustment will be made in the application of the provisions set forth herein
with respect to the rights and interest thereafter of the Warrantholder, to
the
end that the provisions set forth herein will thereafter be applicable, as
nearly as reasonably may be, in relation to any shares of stock or other
property thereafter deliverable upon the exercise of the Warrant. The Company
will not permit any change in its capital structure to occur unless the issuer
of the shares of stock or other securities to be received by the holder of
this
Warrant, if not the Company, agrees to be bound by and comply with the
provisions of this Warrant.
(c) When
any
adjustment is required to be made in the number of Shares or other securities
or
property purchasable upon exercise of the Warrant, the Company will promptly
determine the new number of such Shares or other securities or property
purchasable upon exercise of the Warrant and (i) prepare and retain on file
a
statement describing in reasonable detail the method used in arriving at the
new
number of such Shares or other securities or property purchasable upon exercise
of the Warrant and (ii) cause a copy of such statement to be mailed to the
Warrantholder within thirty (30) days after the date of the event giving rise
to
the adjustment.
(d) No
fractional shares of Common Stock or other securities will be issued in
connection with the exercise of the Warrant, but the Company will pay, in lieu
of fractional shares, a cash payment therefor on the basis of the mean between
the bid and asked prices of the Common Stock in the over-the-counter market
or
the closing price on a national securities exchange on the day immediately
prior
to exercise.
(e) If
securities of the Company or securities of any subsidiary of the Company are
distributed pro rata to holders of Common Stock, such number of such securities
will be distributed to the Warrantholder or his assignee upon exercise of this
Warrant as the Warrantholder or assignee would have been entitled to if the
portion of the Warrant evidenced by this Warrant certificate had been exercised
prior to the record date for such distribution. The provisions with respect
to
adjustment of the Common Stock provided in this Section 4 will also apply to
the
securities to which the Warrantholder or his assignee is entitled under this
subsection 4(e).
(f) In
the
event (i) the Company establishes a record date to determine the holders of
any
class of securities who are entitled to receive any dividend or other
distribution or (ii) there occurs any change in the Common Stock through merger,
consolidation, reclassification, reorganization, partial or complete
liquidation, purchase of substantially all of the assets of the Company or
other
change in the capital structure of the Company, the Company shall give to the
holder hereof a notice specifying (a) the date of such record date for the
purpose of such dividend or distribution and a description of such dividend
or
distribution, (b)
the
date
on which any such merger, consolidation,
reclassification,
reorganization, sale, liquidation or other change in the capital structure
of
the Company is expected to become effective, and (c)
the
time,
if any, that is to be fixed, as to when the holders of record of Common Stock
(or other securities) shall be entitled to exchange their shares of Common
Stock
(or other securities) for securities or other property deliverable upon such
merger, consolidation, reclassification, reorganization, sale, liquidation
or
other change in the capital structure of the Company. Such written notice shall
be given to the holder of this Warrant at least twenty (20) days prior to the
date specified in such notice on which any such action is to be
taken.
5. Reservation
of Shares.
The
Company agrees that the number of shares of Common Stock or other securities
sufficient to provide for the exercise of the Warrant upon the basis set forth
above will at all times during the term of the Warrant be reserved for exercise.
If at any time the Company does not have a sufficient number of shares of Common
Stock or other securities authorized to provide for the exercise of the Warrant,
the Company shall take such actions as may be reasonably necessary to increase
the number of authorized shares of Common Stock or other securities to provide
for exercise of the Warrant.
6. Validity
of Shares.
All
Shares or other securities delivered upon the exercise of the Warrant will
be
duly and validly issued in accordance with their terms, and, in the case of
capital stock, will, when issued and delivered in accordance with their terms
against payment therefor as provided in the Warrant, be fully paid and
nonassessable, and the Company will pay all documentary and transfer taxes,
if
any, in respect of the original issuance thereof upon exercise of the
Warrant.
7. Restrictions
on Transfer.
This
Warrant and the Shares may not be sold, transferred, assigned or hypothecated
except as permitted pursuant to Section 2.6 of the Securities Purchase Agreement
and subject to the restrictions on transfer in the Registration Rights
Agreement. The Warrant may be divided or combined, upon request to the Company
by the Warrantholder, into a certificate or certificates evidencing the same
aggregate number of Warrants.
8. No
Rights as a Stockholder.
Except
as otherwise provided herein, the Warrantholder will not, by virtue of ownership
of the Warrant, be entitled to any rights of a stockholder of the Company but
will, upon written request to the Company, be entitled to receive such quarterly
or annual reports as the Company distributes to its stockholders.
9. Notice.
Any
notices required or permitted to be given under the terms of this Warrant must
be sent by certified or registered mail (return receipt requested) or delivered
personally or by courier (including a recognized overnight delivery service)
or
by facsimile and will be effective five (5) days after being placed in the
mail,
if mailed by regular U.S. mail, or upon receipt, if delivered personally, by
courier (including a recognized overnight delivery service) or by facsimile,
in
each case addressed to a party. The addresses for such communications
are:
If
to the
Company:
Chief
Financial Officer
Sonus
Pharmaceuticals, Inc.
22026
20th Avenue S.E.
Bothell,
Washington 98021
fax: (425)
489-0626
If
to a
Warrantholder: to the address set forth immediately below the Warrantholder’s
name on the signature pages hereto.
With
copies to:
Schering
AG
Legal
Department
170-178
Muellerstrasse
D-13342
Berlin, Germany
Fax: +49-(0)30-468-14086
Each
party will provide written notice to the other parties of any change in its
address.
10. Applicable
Law.
This
Warrant will be governed by and construed in accordance with the laws of the
State of New York, without reference to conflict of laws principles
thereunder.
11. Entire
Agreement.
This
Warrant, the exhibits and schedules hereto, and the documents referred to
herein, constitute the entire agreement and understanding of the parties hereto
with respect to the subject matter hereof, and supersede all prior and
contemporaneous agreements and understandings, whether oral or written, between
the parties hereto with respect to the subject matter hereof.
12. Waiver;
Consent.
This
Warrant may not be changed, amended, terminated, augmented, rescinded or
discharged (other than by performance), in whole or in part, except by a writing
executed by the parties hereto, and no waiver of any of the provisions or
conditions of this Warrant or any of the rights of a party hereto shall be
effective or binding unless such waiver shall be in writing and signed by the
party claimed to have given or consented thereto.
13. No
Impairment.
The
Company will not, by amendment of its Charter or by any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of
this
Warrant, but will at all times in good faith assist in the carrying out of
all
such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the Warrantholder of this Warrant
against impairment.
14. Remedies.
The
Company stipulates that the remedies at law of the Warrantholder of this Warrant
in the event of any default or threatened default by the Company in the
performance of or compliance with any of the terms of this Warrant are not
adequate and may be enforced by a decree for the specific performance of any
agreement
contained
herein or by an injunction against a violation of any of the terms hereof or
otherwise.
15. Severability.
If one
or more provisions of this Warrant are held to be unenforceable under applicable
law, such provision shall be excluded from this Warrant and the balance of
the
Warrant shall be interpreted as if such provision were so excluded and the
balance shall be enforceable in accordance with its terms.
IN
WITNESS WHEREOF, the parties hereto have executed this Warrant effective as
of
the date set forth below.
Dated
as
of October 17, 2005
SONUS
PHARMACEUTICALS, INC.
By:
/s/
Name:__________________________
Title:___________________________
Agreed
and Accepted as of October 17, 2005
SCHERING
AG
By:
/s/
Name:__________________________
Title:___________________________
Address:
170-178
Muellerstrasse
D-13342
Berlin, Germany
Fax: +49-(0)30-468-11411
Attn: Head
of
Finance
NOTICE
OF EXERCISE
To: SONUS
PHARMACEUTICALS, INC.
The
undersigned hereby elects to purchase __________ shares of Common Stock (the
“Shares”)
of
Sonus Pharmaceuticals, Inc., a Delaware corporation (the “Company”)
pursuant to the terms of the attached Warrant, and tenders herewith payment
of
the purchase price pursuant to the terms of the Warrant.
Please
issue certificates representing the Common Stock purchased hereunder in the
names and in the denominations indicated below.
Please
issue a new Warrant for the unexercised portion of the attached Warrant, if
any,
in the name of the undersigned.
Dated:______________________________________ |
|
________________________________ |
|
|
|
No.
Warrant
Shares:___________________________ |
|
Name:________________________________ |
|
|
|
Print
Name of Stockholder:_______________________________ |
|
Title:_________________________________
|